A challenge against India's patent law filed by Novartis will be heard in the Chennai High Court in India today…Médecins Sans Frontières (MSF) warns that this case may have serious implications for future access to essential drugs worldwide. Novartis is challenging a crucial part of the Indian law…[and] also seeking to have the January 2006 decision to reject its patent application for the cancer drug Gleevec reversed…"People the world over who rely on India as a source of their medicines may be affected if Novartis gets its way", said Ellen 't Hoen, Policy Director at MSF's Campaign for Access to Essential Medicines.